A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Cannabis-based medicines led to a ‘substantial improvement’ in symptoms of BPD, also known as emotionally unstable personality disorder (EUPD).
